A Herpes Simplex Virus (HSV)-2 Single-Cycle Candidate Vaccine Deleted in Glycoprotein D Protects Male Mice From Lethal Skin Challenge With Clinical Isolates of HSV-1 and HSV-2.

Saved in:
Bibliographic Details
Title: A Herpes Simplex Virus (HSV)-2 Single-Cycle Candidate Vaccine Deleted in Glycoprotein D Protects Male Mice From Lethal Skin Challenge With Clinical Isolates of HSV-1 and HSV-2.
Authors: Burn C; Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York., Ramsey N; Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York., Garforth SJ; Department of Biochemistry, Albert Einstein College of Medicine, Bronx, New York., Almo S; Department of Biochemistry, Albert Einstein College of Medicine, Bronx, New York., Jacobs WR Jr; Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York.; Howard Hughes Medical Institute, Albert Einstein College of Medicine, Bronx, New York., Herold BC; Department of Pediatrics, Albert Einstein College of Medicine, Bronx, New York.
Source: The Journal of infectious diseases [J Infect Dis] 2018 Feb 14; Vol. 217 (5), pp. 754-758.
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Oxford University Press Country of Publication: United States NLM ID: 0413675 Publication Model: Print Cited Medium: Internet ISSN: 1537-6613 (Electronic) Linking ISSN: 00221899 NLM ISO Abbreviation: J Infect Dis Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1537-6613
DOI:10.1093/infdis/jix628